Yusuke Shimizu

Toyoake, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancer.

Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: January 29, 2026

A case of anti-N-methyl-D-aspartate receptor antibody encephalitis associated with immature ovarian teratoma.

A case of anti-N-methyl-D-aspartate receptor antibody encephalitis associated with immature ovarian teratoma.

Journal: Fujita medical journal

Published: October 02, 2025

A case of irAE gastritis caused by cemiplimab administration.

A case of irAE gastritis caused by cemiplimab administration.

Journal: Fujita medical journal

Published: June 02, 2025

Impact of TSC2 loss on progression-free survival in uterine carcinosarcoma: A retrospective analysis.

Impact of TSC2 loss on progression-free survival in uterine carcinosarcoma: A retrospective analysis.

Journal: Fujita medical journal

Published: January 27, 2025

Understanding the impact of spatial immunophenotypes on the survival of endometrial cancer patients through the ProMisE classification.

Understanding the impact of spatial immunophenotypes on the survival of endometrial cancer patients through the ProMisE classification.

Journal: Cancer immunology, immunotherapy : CII

Published: October 10, 2024

Development and Validation of Predictive Risk Scores for Ovarian Clear Cell Carcinoma: A Penalized Regression Model.

Development and Validation of Predictive Risk Scores for Ovarian Clear Cell Carcinoma: A Penalized Regression Model.

Journal: Cancer medicine

Published: March 31, 2024

Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer.

Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer.

Journal: Cancer medicine

Published: November 08, 2023

Small Extracellular Vesicles from adipose-derived stem cells suppress cell proliferation by delivering the let-7 family of microRNAs in ovarian cancer.

Small Extracellular Vesicles from adipose-derived stem cells suppress cell proliferation by delivering the let-7 family of microRNAs in ovarian cancer.

Journal: Biochemical and biophysical research communications

Published: August 20, 2023

Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancer.

Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancer.

Journal: Scientific reports

Published: July 28, 2023

Effect of radical trachelectomy on ovarian reserve: A single-institute prospective study.

Effect of radical trachelectomy on ovarian reserve: A single-institute prospective study.

Journal: The journal of obstetrics and gynaecology research

Published: June 28, 2023

Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinoma.

Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinoma.

Journal: International journal of clinical oncology

Published: June 13, 2023

The prognostic significance of DDIT4 in endometrial cancer.

The prognostic significance of DDIT4 in endometrial cancer.

Journal: Cancer biomarkers : section A of Disease markers

Published: June 11, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026